ASAris Sterodimas

Aris Sterodimas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aris Sterodimas has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Prospective Study on Helium-based Plasma Radiofrequency for Management of the Lower Eyelids in Greece

    by Aris MD Sterodimas, Beatriz Md Nicaretta, Agathi Koytsouveli, Argyris Moutafis, Grigoris Md Champsas

    Background: Skin laxity and age-related aesthetic concerns in the lower eyelid area are common focuses for rejuvenation treatments. Although lower blepharoplasty remains the gold standard, it has associated risks and downtime. This study evaluated the efficacy and safety of helium plasma radiofrequency (RF) as a minimally invasive alternative for managing skin laxity in the lower eyelid. Methods: In this single-center prospective study, 16 subjects were treated with helium plasma RF in the lower eyelid area. Blinded review of before-and-after photographs was conducted at day 180 postprocedure. Key outcomes included change from baseline in the snap-back test, medial canthal laxity test, and lateral canthal laxity test, as well as investigator- and subject-assessed global aesthetic improvement at posttreatment days 30, 90, and 180. On day 180, subjects completed a satisfaction questionnaire. Results: All subjects showed improvement in laxity, with 100% achieving grade 0 in the snap-back test by day 180. Independent photographic review success rate was 53% at day 90 and 33% at day 180 largely due to challenges with photographic consistency. Patient satisfaction was high, with 100% of participants noting improvement; 53.3% (8 of 15) were very satisfied, and 40% (6 of 15) were satisfied. All subjects (100%) indicated they would recommend treatment to their friends and family. Conclusions: This study suggests that helium plasma RF is a viable and safe minimally invasive option for improving the aesthetic appearance of the lower eyelid.


  • Open Access

    Helium-Based Plasma Radio Frequency Technology for Subdermal Coagulation in the Forehead: A Preliminary, Single-Center Retrospective Study

    by Aris Sterodimas, Beatriz Nicaretta, Agathi Koytsouveli, Argyris Moutafis, Grigoris Champsas

    Background: Helium plasma radio frequency (RF) has emerged as a minimally invasive option for treating facial laxity. This study aims to evaluate its efficacy and safety for addressing forehead and brow laxity and ptosis. Methods: In this retrospective, single-center study, medical records for 30 consecutive patients treated with helium plasma RF in the forehead and brow from March 2018 to September 2022 were reviewed. Inclusion criteria were age ≥18 years and having undergone treated in the forehead with helium plasma RF. Patients with prior or concurrent brow/forehead interventions were excluded. Primary endpoints were photographic assessments by blinded review and patient satisfaction measured via questionnaire. Results: Of the 30 patients, seven patients consented to photographic review, and all 30 participated in the patient satisfaction questionnaire. Blinded reviewers correctly identified posttreatment images in 71.4% (5/7) of cases. Patient satisfaction was high, with 100% (30/30) reporting visible improvements and willingness to recommend the procedure. Notable improvements included reduced forehead lines (56.7%), elevated eyebrows (46.7%), and a more youthful appearance (46.7%). Adverse effects were minor and expected, with bruising recorded in 20% (6/30) of patients and edema/swelling in 16.7% (5/30) of patients, all resolving within 10 days, without intervention. Conclusion: Helium plasma RF demonstrates significant potential as a minimally invasive treatment for brow and forehead laxity, with high patient satisfaction and a favorable safety profile. These preliminary findings warrant further prospective studies with larger sample sizes to confirm efficacy and long-term benefits. Helium plasma RF may provide a valuable alternative to traditional aesthetic procedures for the forehead and brow. Level of Evidence IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.


  • Open Access

    A Prospective Study on Helium-Based Plasma Radiofrequency for Minimally Invasive Breast Lift Scarless Mastopexy

    by Aris Sterodimas, Argyris Moutafis, Beatriz Nicaretta, Grigorios Champsas

    Background: Although mastopexy addresses breast ptosis, not all patients are willing or able to undergo surgery. Helium plasma radiofrequency (RF) is a minimally invasive alternative to traditional excisional breast lift surgery for mild-to-moderate breast ptosis. Objectives: To assess the efficacy and safety of helium plasma RF for minimally invasive mastopexy. Methods: In this single-center prospective study, 15 patients were treated with helium plasma RF. Before and after photographs were assessed by blinded review 180 days postprocedure. Morphometric analysis and evaluations using investigator- and patient-assessed Global Aesthetic Improvement Scales (I-GAIS and P-GAIS, respectively) were carried out on posttreatment Days 30, 90, and 180. On Day 180, patients completed a satisfaction questionnaire and the Breast-Q scale. Results: At Day 180, the independent photographic review success rate was 73% (11/15). There was improvement in suprasternal notch to nipple distance (−1.2 ± 0.7 cm), midclavicular line to nipple distance (−0.9 ± 0.7 cm), and vertical distance from the suprasternal notch to the lowest point on the base (−1.5 ± 1.0 cm). Morphometric measurement appeared to improve over time, as did improvements in P-GAIS and I-GAIS. All patients (15/15) reported less sagging, higher appearance of breasts on the chest, improved nipple placement, more youthful-appearing breasts, and improved confidence and quality of life on the Breast-Q. There were no adverse events or pain reported during the procedure or follow-ups. Conclusions: This study suggests that helium plasma RF is a well-tolerated and effective minimally invasive option for patients seeking an alternative to traditional breast lift surgery. Level of Evidence: 5 (Therapeutic):


  • Open Access

    Helium Plasma Effect on Breast Stromal-Enriched Lipograft: A Case Report

    by Aris Sterodimas

    : Autologous fat transfer for large volume augmentation, reconstructive, and cosmetic purposes has become more popular due to the inherent biocompatibility, accessibility, and low cost. For volume augmentation, the retention of grafted fat is unpredictable. Several approaches to autologous fat transfer have prepared the donor fat and/or the recipient-site increase fat graft retention as well as the predictability of the retention. This study is the first clinical report on the combination of radiofrequency helium plasma pretreatment of the recipient site and a cell-assisted lipotransfer technique for enhanced fat graft retention. One patient underwent autologous breast augmentation using the stromal-enriched lipograft technique to process the fat prior to injection. Only the right breast received pretreatment using radiofrequency helium plasma after infiltration. The processed fat was injected using a droplet style injector. The patient was followed for 2 years and underwent breast MRI examinations for measurement of the graft volume. The overall fat graft survival after 12 months for the stromal-enriched lipograft was 63%, whereas the survival for the stromal-enriched lipograft in combination with radiofrequency helium plasma was 89%. The addition of biostimulatory techniques to prepare the recipient site for breast augmentation enhanced the fat graft retention. Further clinical studies using radiofrequency helium plasma are required to justify using this modality as a recipient-site preparation technique. Level of Evidence: 5 (Therapeutic):


  • Open Access

    Correction: Cosmetic Breast Augmentation with Autologous Ex Vivo-Expanded Adipose-Derived Mesenchymal Stem/Stromal Cell (Stemform®)-Enriched Fat Grafts: A Study of the First Twenty-Two Real-World Patients

    by Frederik Penzien Wainer Mamsen, Anne Fischer-Nielsen, Jesper Dyrendom Svalgaard, Jesper Due Jensen, Bo Jønsson, Dominik Duscher, Josef Christensen, Michiel Van Leeuwen, Claes Hannibal Kiilerich, Laura Roider, et al.

  • Open Access

    Enhanced Fat Graft Viability and Remodeling Using a Helium-based Radiofrequency Device to Prepare the Recipient Site

    by Paul G. Ruff, Aris Sterodimas

    Background: Improvements to autologous fat grafting for soft tissue augmentation are needed to overcome the unpredictable volume retention. Approaches such as fat harvesting and processing, injection technique, preparation of the recipient site, and supplemental biologics are topics of ongoing research. Here, an energy-based device was investigated as a stimulatory tool for recipient site preparation for improving fat graft retention. Objective: The objective was to measure the stimulatory responses in fat grafts after 4 weeks when using a helium-based radiofrequency device to pretreat the recipient tissue. Methods: Using an autologous fat grafting mouse model, the inguinal fat pad was grafted in a small cranial pocket after either a saline injection alone (control) or a saline injection followed by pretreatment (treated). The fat pad was resected after 4 weeks, sectioned and stained with immunofluorescence markers to investigate tissue remodeling. Results: Pretreatment resulted in higher viability of adipocytes, a higher concentration of viable ASCs in areas of adipose tissue regeneration, and localized macrophages in the areas of regeneration when compared to the control. There was no observable difference in vascularity or angiogenesis. The staining for ASCs was higher in the pretreated group in comparison with the control group (5.0% vs. 3.3%, p=0.36) when using a pixel classifier in QuPath in the viable adipose tissue regions. Conclusions: The use of a helium-based radiofrequency device as a pretreatment tool appears to increase the viability of the adipose tissue likely due to higher concentration of ASCs. The apparent increase in viable ASCs may be due to enhanced proliferation or paracrine recruitment of these cells in response to the helium-based radiofrequency treatment. No Level Assigned: This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266. Bullet List of Important Points: Pretreatment of the fat graft recipient site increases the viability of the adipose tissue after 4 weeks in comparison with the control grafts. The increased viability is likely due to the observed increase in adipose-derived stem cells in the pretreated group. Pretreatment enhanced the adipose tissue remodeling as colocalization of adipose-derived stem cells and macrophages showed an active remodeling, whereas the control group exhibited more necrotic and fibrotic tissue.


  • Open Access

    Cosmetic Breast Augmentation with Autologous Ex Vivo-Expanded Adipose-Derived Mesenchymal Stem/Stromal Cell (Stemform®)-Enriched Fat Grafts: A Study of the First Twenty-Two Real-World Patients

    by Frederik Penzien Wainer Mamsen, Anne Fischer-Nielsen, Jesper Dyrendom Svalgaard, Jesper Due Jensen, Bo Jønsson, Dominik Duscher, Josef Christensen, Michiel Van Leeuwen, Claes Hannibal Kiilerich, Laura Roider, et al.

    Background: Fat grafting is commonly utilized in breast surgery, and since it was first described, clinicians and researchers have stridden towards improvement of graft retention. Current advancements include adding adipose-derived mesenchymal stem/stromal cells (MSC(AT)s), which have demonstrated promise for improved graft retention. Objectives: This study reports outcomes for the first twenty-two patients undergoing breast augmentation (Stemform BA) or artificial implant replacement (Stemform AIR) with MSC(AT)-enriched fat in a real-world setting. Methods: Autologous MSC(AT)s were isolated and expanded ex vivo, then mixed with lipoaspirate and injected as enriched fat for Stemform BA and AIR. The breast volume was measured preoperatively and at 3 and 12 months postoperative using a 3D Infinity Dual-Lens Camera and LifeVizApp software. Additionally, independent plastic surgeons evaluated clinical images, and patient satisfaction was obtained at equal time points. Results: Twenty-two patients were included. All completed 3 and 12 months clinical follow-up and 3 months volume measurements. Nineteen patients completed 12 months volume measurements. The median fat graft retention at 12 months was 95.7% (IQR = 82.44–103.12%) for Stemform BA patients and 113.0% (IQR = 94.8–131.2%) for Stemform AIR patients. The Stemform BA patients had a median breast enlargement of 172.0% (IQR = 156.7–241.0%). The implant replacement volume of Stemform AIR patients was 102% (IQR = 85.1–130.3%). The patient reported 92.8% and 100% would elect to repeat treatment if they had the opportunity for Stemform BA and Stemform AIR, respectively. Conclusion: Breast augmentation and breast implant replacement patients receiving ex vivo-expanded MSC(AT)-enriched fat grafts had high graft retention and patient satisfaction scores. The paper confirms the clinical efficacy of using ex vivo-expanded MSC(AT)s. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.